Cell Impact AB (publ) (STO:CI)
Sweden · Delayed Price · Currency is SEK 0.0680
-0.0019 (-2.72%)
Jul 24, 2026, 5:29 PM CET
Cell Impact AB Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4.16 | 2.07 | 26.85 | 48.58 | 93.03 | 81.8 |
Revenue Growth | -80.50% | -92.31% | -44.73% | -47.79% | 13.73% | 179.09% |
Gross Profit Gross Profit Growth | -2.4 | -4.97 | 6.01 | 25.85 | 38.45 | 34.88 |
Operating Income Operating Income Growth | -123.7 | -127.92 | -99.02 | -119.49 | -103.47 | -78.04 |
Net Income Net Income Growth | -128.93 | -131.98 | -100.43 | -121.4 | -104.22 | -79.85 |
Earnings Per Share EPS Growth | -0.72 | -0.78 | -1.62 | -11.10 | -13.80 | -13.50 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Sweden Sweden Growth | 1.9 | 1.7 | 0.26 | 1 | 1.35 | 0.62 |
Other Europe Other Europe Growth | - | 1.45 | 5.91 | 0.34 | 0.47 | 0.02 |
US US Growth | - | 0.9 | 25.05 | 45.01 | 73.1 | 64.18 |
Asia Asia Growth | - | 1.52 | 6.11 | 0.91 | 1.89 | 6.52 |
Total Total Growth | 5.78 | 5.57 | 37.33 | 47.26 | 76.81 | 71.35 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3.95 | 10.86 | 20.39 | 99.89 | 164.67 | 28.56 |
Total Debt Total Debt Growth | 14.87 | 26.63 | 30.92 | 42.75 | 44.7 | 19.51 |
Net Cash (Debt) Net Cash Growth | -10.92 | -15.77 | -10.53 | 57.15 | 119.97 | 9.05 |
Net Cash Growth | - | - | - | -52.37% | 1225.78% | -93.04% |
Net Cash Per Share Net Cash Per Share Growth | -0.05 | -0.09 | -0.06 | 5.21 | 15.84 | 1.53 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -44.3 | -45.36 | -62.23 | -105.83 | -105.93 | -86.08 |
Capital Expenditures CapEx Growth | -1.46 | -1.93 | -12.4 | -50.46 | -62.44 | -52.97 |
Free Cash Flow Free Cash Flow Growth | -45.76 | -47.29 | -74.64 | -156.29 | -168.37 | -139.05 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -57.66% | -240.68% | 22.40% | 53.22% | 41.33% | 42.64% |
Operating Margin | -2975.63% | -6194.43% | -368.85% | -245.99% | -111.21% | -95.40% |
Pretax Margin | -3100.46% | -6391.23% | -373.79% | -249.85% | -111.94% | -97.47% |
Profit Margin | -3099.42% | -6390.99% | -373.48% | -249.77% | -111.87% | -97.32% |
FCF Margin | -1100.79% | -2290.07% | -278.02% | -321.75% | -180.98% | -169.99% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 5.62 | 22.97 | 3.71 | 2.74 | 2.83 | 7.82 |